Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001104659-24-022562 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-13	2024-02-09	INSP	Herbert Timothy P.	CEO, Pres, Dir	A - Grant	$0.00	+8,467	9,690	+692%	$0
D	2024-02-13	2024-02-09	INSP	Herbert Timothy P.	CEO, Pres, Dir	A - Grant	$0.00	+13.8K	13.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-09	A	A	8,467	$0.00	9,690	D	—	—	(F1) Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. (F2) Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023.
2	Derivative	Employee Stock Option (Right to Buy)	2024-02-09	A	A	13,755	$0.00	13,755	D	$194.87 · — to 2034-02-09	13,755 Common Stock	(F7) The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.